Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: non-small cell lung cancer

Francis Crick, UCL and AZ identify why treatment fails for NSCLC patients

Francis Crick, UCL and AZ identify why treatment fails for NSCLC patients
p p Read More

NSCLC accounts for around 85% of all lung cancer cases, particularly in non-smoking patients

June 14, 2024 astrazeneca, EGFR mutations, Francis Crick Institute, News, non-small cell lung cancer, osimertinib, p53 mutations, Tagrisso, University College London

Study suggests tumour microenvironments could predict cancer progression

NSCLC is the most common type of lung cancer and is responsible for up to 85% of all […]

April 12, 2024 Bristol Myers Squibb, Cancer Research UK, Francis Crick Institute, lung cancer, News, non-small cell lung cancer, Oncology, TRACERx, University College London
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy